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HIGHLIGHTS 
 
 Povidone iodine hand-scrub solutions, which are considered safe antiseptics, contain large 
amounts of iodine that can be absorbed by skin. 
 Iodine can be absorbed through intact skin in time dependent manner. 
 In professional use the repetitive contact with PI, also as soap, can cause iodine skin 
permeation that must be considered when the washing procedures are repeated more than 20 
times a day. 
 
ABSTRACT 
Povidone iodine is a water-soluble complex used to disinfect the skin surface and it exerts 
prolonged germicidal action against a broad spectrum of germs. Indeed, it is often applied on 
burned skin, large wounds, deep tissues or mucosa. Notably some surgical hand-scrub solutions, 
which are considered safe antiseptics, contain large amounts of iodine that can be absorbed by skin. 
The aim of present study was to study the skin absorption of iodine after the application on the skin 
of povidone-iodine solution, used by health care workers during surgical procedure. We use Franz 
diffusion static cells with human skin. After 24 h from the beginning of our measurement the iodine 
concentration in the receiving compartment was11.59 ± 6.3 µg/cm2. The medium flux calculated 
was 0.73 ± 0.33 µg/cm2/h with a lag time of 8.9 ± 1.5 h. These in vitro results confirmed that 
povidone iodine could pass through the skin in a relevant amount that can explain the clinical 
findings in burned or surgically treated patients. In professional use the repetitive contact with 
povidone iodine, also as soap, can cause iodine skin permeation that must be considered when the 
washing procedures are repeated more than 20 times a day. 
 
Introduction 
 
Povidone iodine (PI) is a water soluble complex used to disinfect the skin surface and it exerts 
prolonged germicidal action against a broad spectrum of germs as gram-positive and gram-negative 
bacteria, including antibiotic resistant organism, as well as fungi, viruses, protozoa and yeasts 
(Furudate et al., 1997). The bactericidal action of iodine-based disinfectants is caused by free 
molecular iodine. Because of its excellent penetration and its poor reactivity with protein 
constituents(it reacts under the conditions prevailing at disinfection only with S–H functions) iodine 
easily enters the skin where it forms a solid solution. In the case of Lugol’s solution (strong iodine 
solution) this produces a dark brown staining which cannot be removed by washing with soap and 
water or by moistening with reducing material. It decreases only very slowly and in the case of 
strong iodine loads can be observed even after 12 h. The decrease in the absorbed iodine has two 
causes: one part diffuses into deeper skin layers where it is reduced to iodide and produces an 
increase of serum-iodide, while the other part diffuses back out of the skin (Gottardi,  1995). 
One  of  the  most  important  external  uses  of  iodine  is  as disinfectant in skin soaps. Notably 
some surgical hand-scrub solutions, which are considered to be safe antiseptics, contain large 
amounts of iodine and are commonly used as broad-spectrum disinfectants  (Erdogan  et  al.,  2013).  
The  most  studies  which reported the effect of iodine disinfectant are limited to patients only, but 
there is also an occupational exposure to be considered. With regard to transcutaneous iodine 
absorption in healthy adults, only a few studies or cases have been reported (Erdogan et al., 2013). 
Some of the occupations that involve iodine exposure are those in operating rooms where hand 
scrubbing is done with iodine-containing solutions (Erdogan et al., 2013). Besides a wide use for 
skin antisepsis, PI is also employed internally. Indeed, it is often applied on burned skin, large 
wounds, deep tissues or mucosa (Lakhal et al., 2011). In patients where the burned injury spread 
over 25% of the skin surface with deep second- and third- degree burns, the serum total iodine 
levels have been reported to markedly increase to 4500–48,000 mcg/dl and possible systemic 
complications due to elevated free iodine levels have been reported (Aiba et al., 1999). 
The amount of absorption is higher in cases of skin damage or the presence of thinner skin, 
therefore this effect was noted in infants (Erdogan et al., 2013; Findik et al., 2010). In animal 
experiments, transcutaneous absorption of PI through healthy skin has also been examined using 
radioisotope I125 (Furudate et al., 1997). 
In individuals with dysregulation of the thyroid follicular cell, excess iodine exposure can induce 
thyroid dysfunction, which might be transient or permanent (Leung and Braverman, 2014). 
The aim of our study was to calculate the skin absorption of iodine after the application on the skin 
of povidone-iodine solution used by health care workers during surgical procedures. We use the 
protocol defined during the European project EDETOX (Evaluations and predictions of DErmal 102 
absorption of TOXic chemicals), a three-year  research  program  (2001–2004)  founded by 
European Union (EDETOX, 2000) and used to test the skin permeation of chemicals and metals 
(Filon et al., 2006). 
 
Materials and methods 
 
Chemicals 
 
All chemicals were analytical grade. Urea, disodium hydrogen phosphate, potassium dihydrogen 
phosphate, hydrogen peroxide (30% v/v) were purchased from Carlo Erba (Milan, Italy); lactic acid 
(90%) from Acros Organics (Geel, Belgium); sodium chloride, ammonium hydroxide (25% w/v), 
nitric acid (>69% v/v) from Sigma–Aldrich (Milan, Italy). 
The povidone-iodine solution (10%) used in the experiments is a stable chemical complex of 
polyvinylpyrrolidone (povidone, PVP) and elemental iodine (Esoform Jod 75, that contains 10% 
(7.5 g) of polyvinylpyrrolidone–iodine with 0.75% of active iodine; Esoform S.P.A. Laboratorio 
Chimico Farmaceutico, Via del Lavoro 10, Rovigo, Italy). 
Water reagent grade was produced with a Millipore purification pack system (milliQ water). The 
physiological solution used as receptor fluid was freshly prepared by dissolving 9 g of NaCl, 2.38 g 
of Na2HPO4 and 0.19 g of KH2PO4 into 1 l of milliQ water (final pH 7.35). The synthetic sweat 
solution used as donor fluid consisted of 0.5% sodium chloride, 0.1% urea and 0.1% lactic acid in 
milliQ water; pH 4.5 was adjusted with ammonia. 
 
Preparation of skin membranes 
 
Human abdominal full thickness skin was obtained as surgical waste after the authorization of the 
local Ethical Committee and it was used for the absorption experiments immediately after the 
surgical operations. Prior to freezing, the subcutaneous fat was removed and the hair shaved with a 
razor. All the pieces of full thickness skin were stored in freezer at -25 o C for a period up to, but 
not exceeding, two months. It has been shown that this method of storage does not damage the skin 
since no difference in permeability was observed between fresh and frozen segments of the same 
skin in a separate series of experiments (Franz, 1975). 
From each skin specimen, 4 x 4 cm2 pieces were cut and mounted separately on the diffusion cells, 
that were previously washed the first time with freshly prepared aqua regia, the second time with 
diluted nitric acid, and rinsed three times with milliQ water. 
Skin integrity was tested before and after each experiment using electrical conductibility by means 
of a conductometer (Metrohm, 660, Metrohm AG Oberdorfstr. 68 CH-9100 Herisau) operating at 
300 Hz and connected to two stainless steel electrodes (Fasano et al., 2002). The conductibility data 
in mS were converted into KΩ cm-2. Cells with a resistance lower than 3.95 ± 0.27 KΩ cm-2 were 
considered to be damaged and rejected as suggested by Davies et al. (2004). 
 
In vitro diffusion system 
 
Percutaneous absorption studies were performed using static diffusion cells following the Franz 
method (Franz, 1975). The receptor compartment had a mean volume of 14.0 ml and was 
maintained at 32 oC by means of circulation of thermostated water in the jacket surrounding the cell. 
This temperature value was chosen in order to reproduce the hand physiological temperature at 
normal conditions. The solution in each cell was continuously stirred using a Teflon coated 
magnetic stirrer. 
Each piece of skin was clamped between the donor and the receptor compartment; the mean 
exposed skin area was 3.29 cm2 and the average membranes  thickness was 0.9 mm. For each 
experiment, the skin of 2 different donors, male and female, with a range of age from 50 to 70 years 
was used. 
 
The experiment 
 
The experiments were carried out as follows: 
Experiment 1: at time 0, the exposure chambers of 6 Franz diffusion cells were filled with 1.0 ml of 
synthetic sweat and 2.0 ml of the povidone-iodine solution (10%) providing an amount of 0.606 g 
cm-2 of iodine in order to ensure an infinite dose. At selected intervals (2, 4, 6, 8, 12, 20 and 24 h) 
1.5 ml of the dermal bathing solution was removed and collected for the analyses. Each receptor 
sample was immediately replaced with an equal volume of fresh made physiological solution. At 24 
h, the dermal bathing solutions were removed and stored in the freezer, the donor solutions were 
collected in order to verify the iodine concentration in the donor phase. 
 
Experiment 2: experiment 1 was repeated miming the hand washing protocol used by nurses and 
medical doctors during surgery in Trieste Hospitals: each donor chamber has been filled with 1.0 ml 
of the povidone-iodine solution (10%) and the skin has been carefully washed with a cotton balls 
for two minutes. After that, the skin surface has been rinsed three time with 2.0 ml of physiological 
solution. The washing operation has been repeated twice. At selected intervals (1, 2, 4, 6, 8, 12, 20 
and 24 h) 1.5 ml of the dermal bathing solution was removed and collected for the analyses. Each 
receptor sample was immediately replaced with an equal volume of fresh made physiological 
solution. At 24 h, the dermal bathing solutions were removed and stored in the freezer, the donor 
solutions were collected in order to verify the iodine concentration in the donor phase. 
 
Blanks: for each experiment, one cell was added as blank. The blank cells were treated as the other 
cells with the exception that no povidone-iodine solution (10%) has been introduced to the exposure 
chamber, but only synthetic sweat. 
As the equipment used was static, there is no relationship between the cells tested, hence each of 
them represents an independent  evaluation. 
 
Analytical measurements 
 
ICP-MS 7500 CE Agilent Technologies Inc., Santa Clara, CA, USA instrument (with integrated 
autosampler) was used to determinate  the  total  iodine  concentration  in  the  receiver  phases.  A 
five-point standard curve was used for ICP-MS measurements (0, 0.1,1,10, and 100 µg/l-1, ion mass 
127 u.m.a.). The limit of detection of iodine was 0.002 µg/l-1 and the precision of the measurements 
as repeatability (RSD%) for the analysis was always <2%. 
 
Data analysis 
 
Iodine concentration data (µg/cm-3) in the receptor solution were converted to the total amount that 
penetrated (µg/cm-2), with a correction for dilution due to sample removal. 
Data analysis was performed using the statistical software SPSS for Windows (version 15.0). Data 
are reported as mean ± standard deviation (SD). The difference between independent data was 
assessed by means of the Mann–Whitney and Kruskal–Wallis tests. A p value of <0.05 was 
considered as the limit of statistical significance. 
 
Results 
 
Estimation of free-iodine concentration by iodine permeation assay through the skin 
 
As we assumed the concentration of iodine in the acceptor compartment increased linearly over 
time in proportion to contact time between iodine and the intact skin in the donor compartment 
(Table 1). The slope of the graph reflects the permeability speed of free-iodine (Fig. 1). After 24 h 
from the beginning of our measurement the  concentration  in  the  acceptor compartment was 11.59 
± 6.3 µg/cm2, the total amount of iodine diffusing out during this period is proportional to the total 
iodine absorbed by the  bloodstream.  The  medium  flux  calculated  was  0.73 ± 0.33 
µg/cm2/h and the lag time was 8.9 ± 1.5 h. 
 
Residual effect of skin iodine 
 
Even though the first two test tubes were marked as blank, we measured an increased concentration 
of free iodine in the acceptor compartment due to the presence of iodine into the skin and in 
synthetic sweat used in the donor phase. Fig. 2 shows the increase in the concentration of iodine in 
the course of  the first approximately 8 h until it reaches the plateau. 
 
Influence of contact time 
 
Iodine concentration in the receiving phases after the washing protocol is reported in Table 2. After 
one hour we find an increase of iodine content that decreased over time reaching the same values of 
control cells (Fig. 2). 
Fig. 2 shows that iodine flux is dependent on contact time (experiments with operating room 
protocol). The influence of contact time on free iodine flux was evaluated by applying the 
commercial preparation (Esoform) for 2 min and measuring the concentration of free-iodine in the 
receptor compartment by one-hour intervals. 
The obtained results clearly show that also PI that has been washed out after its application is 
absorbed into the bloodstream during the first hour. 
 
Discussion 
 
Our study on percutaneous absorption of  iodine shows a significant permeation of iodine through 
the skin that is time of contact dependent. Our experimental data confirmed for the first time in vitro 
what has been reported in other clinical studies on patients who underwent surgical procedures or 
burned. In a previous clinical investigation by Dela Cruz et al. (1987), it was underlined that the 
reports of iodine absorption from topical povidone iodine solution suggest that the absorption is 
enhanced when the compound is applied to denuded skin, mucosal surface with high absorptive 
capacity or extensive areas of intact skin. The evidence for iodine absorption of most of these 
studies includes documented serum iodine concentration and thyroid function abnormalities. 
Kovacikova et al. (2005) investigated thyroid function and ioduria in infants after cardiac surgery 
with primary sternal closure compared with delayed sternal closure (DSC) and the exposure to 
povidone iodine for sternal wound protection. The patients with DSC display more profound 
thyroid suppression in the immediate postoperative period. The use of PI adhesive drapes with 
single iodine mediastinal irrigation in patients with DSC is associated with significant iodine 
absorption but no significant thyroid dysfunction. Also Mitchell et al. (1991) established a fourfold 
concentration rise of total plasma iodine (range 160– 1.440%) after PI skin preparation of infants 
undergoing closed cardiac or thoracic procedures (covering 20–30% of body surface by povidone 
iodine). PI applications to surgical wounds of neonates with giant omphalocele were studied by 
Whitehouse et al. (2010) who concluded that topical PI promotes escharification and 
epithelialisation and may cause transient TSH elevation especially in the early phase of treatment. 
PI gel is a widely used topical microbial agent in cases of burn injured patients. The free iodine is 
released at a slow rate from this complex at the treated site, where it acts as a bactericidal and 
fungicidal agent, especially in longer protracted cases (Aiba et al., 1999). A possibly collateral 
effect of this therapy is the excessive iodine systemic absorption. In fact, Edna and Bernard (1985) 
found that an increase of 1% iodine in the treated area contributed to an increase of 30 mcg iodine 
per 100 ml of serum. 
In the patients with a normal renal function, the serum iodine level continues to rise until the 
discontinuation of drug administration. More than 1 week is required for the serum iodine level to 
return to normal after the last iodine application (Steen, 1993). 
Below in 2006 underlined that 0.3–4.5% of the iodine of the PI is absorbed through the skin, 
depending on the concentration and the size of the area to which it is applied. Miller et al. (1985) 
reported that topical application of tincture or PI to the skin of rats was found to be as effective as 
oral administration of potassium iodine in blocking thyroid uptake of parenterally administrated 
iodine-131. Gosset et al. (2008) used PI for cavity clearance in a 62-years-old patient with post-
pneumonectomic empyema after an operation for non-small cell lung cancer. They reported in 2008 
that the patient suffered from thyrotoxicosis as a result of the therapy and the patient should be 
monitored during management (Gosset et al., 2008). Moreover, the iodine used during cataract 
surgery  is  absorbed  by  the  body  and  that  the  use  of  PI  is contraindicated in patients with 
thyroid pathology (Below et al., 2006). 
In previous studies, it was also shown that PI use in preoperative preparations made for vaginal 
disinfection (daily vaginal douche and mouthwash) was associated with increased serum and urine 
iodine levels (Tomoda et al., 2005; Vorherr et al., 1980; Nobukuni and Kawahara, 2002; Ader et al., 
1988). 
Furudate   et   al.   (1997)   investigated   the   125I   uptake competing with iodine absorption by the 
thyroid gland following povidone iodine skin application in mice and rats and the PI application 
group showed a significant decreased uptake of 125I (Furudate et al., 1997). 
Our study confirmed that PI solution can permeate the intact skin in time dependent matter and 
permitted us to define a flux and lag time that can be used to predict iodine absorption into 
bloodstream considering the exposed area of the skin. These values are surely higher when applied 
on impaired skin or on mucosa or on the skin of young babies. 
To  increase  the  knowledge  on  iodine  skin  absorption, we repeated our experiment considering 
the washing protocol used by health care professional during their work in operating rooms in 
Trieste Hospitals. These workers must wash their hand using PI solution for 2 min, than they rinse 
hands using water and they repeat the PI application and the rinsing. This procedure is repeated 
many times during the day (20–30 times). The obtained results clearly show that also PI that has 
been washed out after its application is absorbed into the bloodstream during the first hour. It can be 
concluded that the greatest part of PI is absorbed into the bloodstream after the washing of hands in 
the course of the first hours following the contact. It is already demonstrated that  a  washing  
procedure  can  enhance  skin  permeation  due probably to the action of soap and water that can 
alter skin surface (Filon et al., 2006). 
In the occupational field there are two clinical studies that confirmed our results by urinary iodine 
concentration in vivo. The first study was conducted with a limited number of nonsurgical ward 
nurses, who had to use PI products for hand washing and gargling several times a day in Japan 
(Nobukuni and Kawahara, 2002). Although it was demonstrated that the serum levels of iodine did 
not significantly increase in the group using PI, the mean serum-free thyroxine levels were slightly, 
but not significantly, higher compared to the controls. However, this study include only small group 
of nurses, and the mucosal or cutaneous exposure time to the PI products were short. The second 
study investigated the effect of hand scrubbing with iodine-containing solutions on urinary iodine 
concentrations of the operating room staff. Erdogan et al. (2013) demonstrated that the operating 
room staff can have significantly higher levels of urinary iodine concentration (UICs) compared 
with the staff from nonsurgical units, probably due to high exposure time and also the operating 
rooms staff might be exposed to more gaseous forms of iodine because of the large number of 
people using hand scrubs within the same time-frame and it is the same scrubbing sinks, in addition 
to the topical, preoperatively applied PI on patients in the operating room. In nearly 40% of the staff 
using solely the iodine-containing scrub solution, urinary iodine concentrations were >300 mcg/l. 
According to World Health Organization a median urinary iodine level >300 mcg/l indicates 
excessive iodine intake for a surveyed population and can be associated with adverse health 
consequences (Erdogan et al., 2013). Anyway  the  in  vitro  design  of  our  study  deserve  some 
limitations: 
 
1. When assessing the results obtained in vitro it is necessary to consider the difference 
between the artificial character of the experimental studies conducted in vitro and reality; because 
the extrapolation  to  “real-world”  events  is  an  imperfect  art (Filon et al., 2006). 
2. Absorption of a topical substance through the skin is most notably influenced by 
concentration, contact duration, frequency, and exposed area. The interplay between these factors, 
along with skin biology and physiochemical properties of the penetrant, can lead to enhanced 
percutaneous penetration (Blickenstaff et al., 2014). 
3. Furthermore, we have to consider that in the first part of our experimental study we applied 
the infinite dose in the donor compartment and we demonstrated that the iodine concentration in the 
receptor compartment increased linearly over time in proportion to contact time between iodine and 
the intact skin in the donor compartment. This situation could be similar in cases of wide use of PI 
during surgical procedures and as a topical antiseptic of skin, mucosa, wound or deep tissues 
(Tomoda et al., 2005; Paul et al., 1988; Zafer et al., 1992). 
4. Nevertheless, it is also necessary to take into consideration that during the surgical hand 
washing the operating room staff cover about 9% of the total body surface (20 cm2) with iodine 
containing solutions and scrub it with it. One application to the skin of PI solution can cause the 
absorption of 232 mcg of iodine each time (11.6 mcg/cm2 x 20 cm2) in 24 h, while one application 
with rinsing of PI solution can cause the absorption of 2 mcg of iodine in 1 h for each washing 
procedure (0.10 mcg/ cm2 x 20 cm2). Considering that one worker washes hands and forearms for 
more than 20 times a days the total amount of iodine that can permeate the skin is 40 mcg per day. 
5. In the field of occupational medicine we also have to consider the workers that can suffer 
from dermatitis or other skin pathologies. It was already demonstrated that damaged skin has a 
higher permeation rate to xenobiotics (Filon et al., 2006). 
 
Conclusion 
 
Our study demonstrated in vitro that iodine can be absorbed through the skin when PI antiseptic is 
used in a time and area exposed dependent manner. Iodine is present in different preparations 
including soap, solutions, surgical scrub used by health  care  professionals.  The  repetitive  use  of  
surgical  hand antiseptics containing iodine among the operating-room staff may cause excessive 
iodine exposure by transcutaneous absorption, recently demonstrated in a clinical study with urinary 
iodine assessment (Erdogan et al., 2013) and the increase of iodine serum concentration can cause 
thyroid dysfunction (Dela Cruz et al., 1987; Philippou et al., 1992; Jubiz et al., 1977; Sternthal et al., 
1980; Vagenakis et al., 1974). 
In accordance with previous data a long term use of PI can present a risk for iodine excess-inducing 
thyroid disorders for both patients and medical workers (Nobukuni and Kawahara, 2002; Linder et 
al., 1997; Ader et al., 1988; Bürgi, 2010). 
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Table 1 
Iodine content in receiving phases in blank and treated cells (µg/cm2). 
 
 
 
Table 2 
Iodine concentration in receiving cells after the washing protocol (µg/cm2). 
 
 
 
 
Fig. 1. Skin absorption profiles of iodine through intact skin, compared to blank cells. 
 
 
 
 
 
Fig. 2. Skin absorption of iodine in cell washed compared to blank cells. 
 
 
 
